Concepts (137)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Scleroderma, Systemic | 4 | 2024 | 346 | 2.420 |
Why?
|
| Dermatology | 9 | 2023 | 905 | 1.670 |
Why?
|
| Skin Diseases | 5 | 2023 | 1085 | 0.830 |
Why?
|
| Raynaud Disease | 1 | 2021 | 81 | 0.730 |
Why?
|
| Decontamination | 1 | 2021 | 73 | 0.710 |
Why?
|
| Masks | 1 | 2021 | 214 | 0.620 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2021 | 238 | 0.600 |
Why?
|
| Sarcoidosis | 1 | 2021 | 535 | 0.500 |
Why?
|
| Dermatomyositis | 3 | 2023 | 259 | 0.470 |
Why?
|
| Drug Costs | 2 | 2022 | 1195 | 0.460 |
Why?
|
| Academic Medical Centers | 3 | 2022 | 2785 | 0.400 |
Why?
|
| Telemedicine | 4 | 2021 | 3109 | 0.370 |
Why?
|
| Insurance Coverage | 1 | 2020 | 1946 | 0.310 |
Why?
|
| Health Policy | 1 | 2020 | 2697 | 0.290 |
Why?
|
| Vulnerable Populations | 3 | 2021 | 718 | 0.270 |
Why?
|
| Fund Raising | 1 | 2024 | 49 | 0.220 |
Why?
|
| Ecthyma | 1 | 2023 | 8 | 0.220 |
Why?
|
| Physicians | 1 | 2022 | 4598 | 0.220 |
Why?
|
| Arrhythmogenic Right Ventricular Dysplasia | 2 | 2015 | 163 | 0.210 |
Why?
|
| Lichen Sclerosus et Atrophicus | 1 | 2023 | 26 | 0.210 |
Why?
|
| Lichen Nitidus | 1 | 2022 | 4 | 0.210 |
Why?
|
| Scleroderma, Localized | 1 | 2022 | 85 | 0.190 |
Why?
|
| Fasciitis | 1 | 2021 | 66 | 0.180 |
Why?
|
| Pyoderma Gangrenosum | 1 | 2022 | 84 | 0.180 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 2021 | 61 | 0.180 |
Why?
|
| Hidradenitis Suppurativa | 1 | 2023 | 176 | 0.170 |
Why?
|
| Mycophenolic Acid | 1 | 2022 | 348 | 0.170 |
Why?
|
| Autoimmune Diseases | 2 | 2022 | 2257 | 0.170 |
Why?
|
| Humans | 44 | 2024 | 768171 | 0.170 |
Why?
|
| Paraproteinemias | 1 | 2021 | 252 | 0.160 |
Why?
|
| Faculty | 1 | 2022 | 383 | 0.160 |
Why?
|
| Pseudomonas Infections | 1 | 2023 | 623 | 0.160 |
Why?
|
| Disinfection | 1 | 2021 | 207 | 0.160 |
Why?
|
| Indians, North American | 1 | 2022 | 354 | 0.160 |
Why?
|
| Remote Consultation | 1 | 2021 | 242 | 0.150 |
Why?
|
| Skin Neoplasms | 3 | 2023 | 5863 | 0.150 |
Why?
|
| Consumer Health Information | 1 | 2020 | 215 | 0.150 |
Why?
|
| Connective Tissue Diseases | 1 | 2021 | 285 | 0.150 |
Why?
|
| Medicare Part D | 1 | 2022 | 355 | 0.150 |
Why?
|
| Phototherapy | 1 | 2021 | 368 | 0.150 |
Why?
|
| Nose | 1 | 2021 | 523 | 0.140 |
Why?
|
| Eosinophilia | 1 | 2021 | 556 | 0.140 |
Why?
|
| Steroids | 1 | 2022 | 938 | 0.130 |
Why?
|
| Piperidines | 2 | 2021 | 1667 | 0.130 |
Why?
|
| Acne Vulgaris | 1 | 2021 | 352 | 0.130 |
Why?
|
| Schools, Medical | 1 | 2022 | 883 | 0.120 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2023 | 951 | 0.120 |
Why?
|
| Cost of Illness | 1 | 2024 | 1951 | 0.120 |
Why?
|
| Health Education | 1 | 2020 | 1059 | 0.110 |
Why?
|
| Drug Approval | 1 | 2021 | 821 | 0.110 |
Why?
|
| Disabled Persons | 1 | 2023 | 1210 | 0.110 |
Why?
|
| Health Services Accessibility | 2 | 2020 | 5520 | 0.100 |
Why?
|
| Health Expenditures | 2 | 2022 | 2389 | 0.100 |
Why?
|
| Students | 1 | 2022 | 1744 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 1886 | 0.100 |
Why?
|
| Pericardium | 1 | 2014 | 679 | 0.090 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 1882 | 0.080 |
Why?
|
| Education, Medical | 1 | 2021 | 1742 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2021 | 4355 | 0.080 |
Why?
|
| Graft vs Host Disease | 1 | 2022 | 3049 | 0.080 |
Why?
|
| Sepsis | 1 | 2023 | 2608 | 0.080 |
Why?
|
| Pandemics | 4 | 2021 | 8747 | 0.080 |
Why?
|
| Retrospective Studies | 9 | 2023 | 81760 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2021 | 2171 | 0.080 |
Why?
|
| Mental Health | 1 | 2023 | 3275 | 0.080 |
Why?
|
| Students, Medical | 1 | 2021 | 1964 | 0.080 |
Why?
|
| Massachusetts | 1 | 2021 | 8890 | 0.070 |
Why?
|
| Public Health | 1 | 2021 | 2679 | 0.070 |
Why?
|
| Sex Factors | 1 | 2021 | 10632 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 20225 | 0.070 |
Why?
|
| Pain | 1 | 2021 | 5099 | 0.070 |
Why?
|
| Tachycardia, Ventricular | 1 | 2014 | 1309 | 0.060 |
Why?
|
| Immunotherapy | 1 | 2021 | 4754 | 0.060 |
Why?
|
| Healthcare Disparities | 1 | 2020 | 3415 | 0.060 |
Why?
|
| Contraceptive Devices | 1 | 2023 | 25 | 0.060 |
Why?
|
| Contraceptive Agents | 1 | 2023 | 148 | 0.050 |
Why?
|
| Ointments | 1 | 2021 | 58 | 0.050 |
Why?
|
| Catheter Ablation | 1 | 2014 | 2780 | 0.050 |
Why?
|
| Quality of Life | 1 | 2023 | 13490 | 0.050 |
Why?
|
| United States | 7 | 2023 | 73039 | 0.050 |
Why?
|
| Female | 8 | 2024 | 397187 | 0.040 |
Why?
|
| Isotretinoin | 1 | 2022 | 134 | 0.040 |
Why?
|
| Prescriptions | 1 | 2022 | 388 | 0.040 |
Why?
|
| Contraception | 1 | 2023 | 362 | 0.040 |
Why?
|
| Awareness | 1 | 2023 | 653 | 0.040 |
Why?
|
| Male | 6 | 2024 | 364731 | 0.040 |
Why?
|
| Pyrimidines | 2 | 2021 | 3048 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2023 | 667 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2021 | 41753 | 0.040 |
Why?
|
| Immunocompromised Host | 1 | 2023 | 863 | 0.040 |
Why?
|
| Polymorphism, Genetic | 2 | 2021 | 4249 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2022 | 643 | 0.040 |
Why?
|
| Middle Aged | 5 | 2024 | 223487 | 0.030 |
Why?
|
| Temperature | 1 | 2023 | 2234 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2022 | 1667 | 0.030 |
Why?
|
| Patients | 1 | 2023 | 908 | 0.030 |
Why?
|
| Desmocollins | 1 | 2015 | 12 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2022 | 791 | 0.030 |
Why?
|
| Desmoglein 2 | 1 | 2015 | 11 | 0.030 |
Why?
|
| Video Recording | 1 | 2020 | 976 | 0.030 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2023 | 1276 | 0.030 |
Why?
|
| gamma Catenin | 1 | 2015 | 45 | 0.030 |
Why?
|
| Plakophilins | 1 | 2015 | 32 | 0.030 |
Why?
|
| Desmoplakins | 1 | 2015 | 63 | 0.030 |
Why?
|
| Epicardial Mapping | 1 | 2014 | 58 | 0.030 |
Why?
|
| Medical Errors | 1 | 2022 | 1260 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 857 | 0.030 |
Why?
|
| Medicare | 2 | 2023 | 6809 | 0.030 |
Why?
|
| Neoplasms | 1 | 2022 | 22371 | 0.030 |
Why?
|
| Income | 1 | 2022 | 1878 | 0.030 |
Why?
|
| Patient Participation | 1 | 2021 | 1447 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2021 | 1596 | 0.020 |
Why?
|
| Aged | 5 | 2023 | 171502 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2022 | 3140 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2021 | 26379 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2022 | 2517 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2022 | 3490 | 0.020 |
Why?
|
| Hospitals | 1 | 2023 | 3886 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2022 | 4206 | 0.020 |
Why?
|
| Skin | 1 | 2022 | 4505 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2023 | 9384 | 0.020 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2015 | 1567 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2020 | 7852 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 13013 | 0.020 |
Why?
|
| Prevalence | 1 | 2023 | 15869 | 0.020 |
Why?
|
| Risk Factors | 2 | 2023 | 74944 | 0.020 |
Why?
|
| Defibrillators, Implantable | 1 | 2015 | 1498 | 0.020 |
Why?
|
| Age Factors | 1 | 2021 | 18415 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6525 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2023 | 7951 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2015 | 39354 | 0.010 |
Why?
|
| Recurrence | 1 | 2014 | 8509 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2023 | 24318 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2014 | 6412 | 0.010 |
Why?
|
| Algorithms | 1 | 2021 | 14164 | 0.010 |
Why?
|
| Adult | 2 | 2021 | 223646 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 65379 | 0.000 |
Why?
|
Concepts
(137)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(32)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_